Skip to content

Drug interactions

Dihydroergotamine intranasal + Paroxetine

Severity: Moderate

Dihydroergotamine intranasal and Paroxetine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents enhance serotonergic activity, so combining them may raise the risk of serotonin syndrome. Paroxetine is also a CYP2D6 inhibitor with some effect on ergot handling, and the clinical evidence for the combination is limited to isolated reports.

What this interaction means in plain words

Dihydroergotamine intranasal and Paroxetine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive serotonergic effects from SSRI reuptake inhibition and ergot 5-HT1 receptor agonism.

What to do

Monitor for agitation, tremor, hyperreflexia, diaphoresis and hyperthermia after starting or increasing either drug. Stop both and treat supportively if serotonin syndrome is suspected.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine intranasal and Paroxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine intranasal with Paroxetine?

MediHelp rates the interaction as moderate. Dihydroergotamine intranasal and Paroxetine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents enhance serotonergic activity, so combining them may raise the risk of serotonin syndrome. Paroxetine is also a CYP2D6 inhibitor with some effect on ergot handling, and the clinical evidence for the combination is limited to isolated reports.

How serious is the interaction between Dihydroergotamine intranasal and Paroxetine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for agitation, tremor, hyperreflexia, diaphoresis and hyperthermia after starting or increasing either drug. Stop both and treat supportively if serotonin syndrome is suspected.

What other medicines interact with Paroxetine?

MediHelp also lists interactions of Paroxetine with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Paroxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in